Atlas Trials

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Clinical trial NCT00478270 · WITHDRAWN

Trial details

NCT number
NCT00478270
Sponsor
Hoffmann-La Roche
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
PainBone NeoplasmNeoplasm Metastasis
Start date
2007-06-01
Primary completion
2008-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.